Celltrion announces publication of post-hoc analysis of LIBERTY-CD study of ZYMFENTRA®  (infliximab-dyyb), indicating consistent efficacy across disease location, including the terminal ileum in Clinical Gastroenterology and Hepatology journal

Findings from the post-hoc analysis of LIBERTY-CD study indicates efficacy of ZYMFENTRA® (subcutaneous…

Vital Signs highlights how researchers are "cracking the code on the genome" to harness the biomedical superpowers of hibernating animals

HONG KONG, Nov. 26, 2025 /PRNewswire/ — In a groundbreaking new episode,…

Gaotu Techedu Announces Third Quarter 2025 Unaudited Financial Results

BEIJING, Nov. 26, 2025 /PRNewswire/ — Gaotu Techedu Inc. (NYSE: GOTU) ("Gaotu"…

Renalys Pharma Announces Positive Topline Results from Phase III Study of Sparsentan in Japanese Patients with IgA Nephropathy

– In a Phase 3 clinical study evaluating the efficacy and safety…

Himeji Convention & Visitors Bureau Introduces Special Winter Events in Himeji City, Home to World Heritage Site Himeji Castle

HIMEJI, Japan, Nov. 26, 2025 /PRNewswire/ — The Himeji Convention & Visitors…

The Adecco Group introduces the agility advantage to grow, adapt and lead in the intelligent era

Agility advantage enables human and business agility across talent and technology solutions…

Korea Innovation Foundation selects 2 Innovative bio health companies, LEEBIO, and Airlab for Global Technology Commercialization Support Program (North America)

DAEJEON, South Korea, Nov. 26, 2025 /PRNewswire/ — Korea Innovation Foundation (INNOPOLIS),…

DESLOC Smart Lock Unveils the World's First Self-Sustained Perovskite Solar Door Lock, Debuting at CES 2026

DESLOC V150 Plus: The World’s First Self-Sustaining Solar Smart Lock, Powered by…